CYTO-MED INC
Business Summary
Develops therapeutic products for treatment of adverse immune reactions, such as asthma, adult respiratory distress syndrome, inflammatory bowel disease, psoriasis, septic shock and life-threatening complications of bone marrow and organ transplantation. The Company has developed several classes of dual function antagonist (DFA), low molecular weight compounds that inhibit lipid mediators through both the action of the platelet activating factor (PA) and the production of leukotrienes (two of the most potent inflammatory mediators).
Country of Incorporation
United States of America
Incorporation Date
1986-05-19
Business Sector
Pharmaceuticals & Medical Research
Company Address
713 Trillium Street
Get access to the below data and more business development tools by signing up for the MENA Company Data product.
- Ownership details
- Corporate structure
- Business classification
- Officers & Directors contact details
- Full company contact details
Multiply your reach by contributing your content to LSEG
LSEG contributed content reaches tens of thousands of buy and sell side professionals around the world through an integrated suite of market intelligence and transaction platforms.NEWS ON THIS COMPANY
TOP PICKS
MOST READ
MOST WATCHED
MOST POPULAR
1.
2.
3.
4.
5.
